NewLink Genetics Corp (NLNK)

14.99
NASDAQ : Health Care
Prev Close 14.99
Day Low/High 0.00 / 0.00
52 Wk Low/High 9.23 / 46.34
Avg Volume 277.20K
Exchange NASDAQ
Shares Outstanding 28.97M
Market Cap 385.87M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving NewLink Genetics Corporation And A Lead Plaintiff Deadline Of July 11, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased NewLink Genetics Corporation (NASDAQ:NLNK)...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of NewLink Genetics Corporation ("NewLink") (NASDAQ: NLNK) between...

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

These 5 Stocks Are Poised for Breakouts

These 5 Stocks Are Poised for Breakouts

These stocks look ready to break out and trade higher from current levels.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of NewLink Genetics Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of July 11, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of NewLink Genetics Corporation ("NewLink") (NASDAQ:NLNK) between...

SHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of NewLink Genetics Corporation And Advises Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces Investigation Of NewLink Genetics Corporation And Advises Investors With Losses To Contact The Firm

Lundin Law PC announces it is investigating claims against NewLink Genetics Corporation ("NewLink" or the "Company") (Nasdaq: NLNK) concerning possible violations of federal securities laws.

NewLink Genetics Presents Clinical Data For IDO Pathway Inhibitor Indoximod Combinations At American Society Of Clinical Oncology (ASCO) Annual Meeting

NewLink Genetics Presents Clinical Data For IDO Pathway Inhibitor Indoximod Combinations At American Society Of Clinical Oncology (ASCO) Annual Meeting

In Two Study Posters, Indoximod Shows Promise in Combination Therapies for Melanoma and Pancreatic Cancer

Commit To Purchase NewLink Genetics Corp At $8, Earn 20% Using Options

Commit To Purchase NewLink Genetics Corp At $8, Earn 20% Using Options

Investors eyeing a purchase of NewLink Genetics Corp stock, but tentative about paying the going market price of $11.17/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $8 strike, which has a bid at the time of this writing of $1.60.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In NewLink Genetics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Today's Dead Cat Bounce Stock Is NewLink Genetics (NLNK)

Today's Dead Cat Bounce Stock Is NewLink Genetics (NLNK)

Trade-Ideas LLC identified NewLink Genetics (NLNK) as a "dead cat bounce" (down big yesterday but up big today) candidate

NewLink Genetics (NLNK) Highlighted As Weak On High Volume

NewLink Genetics (NLNK) Highlighted As Weak On High Volume

Trade-Ideas LLC identified NewLink Genetics (NLNK) as a weak on high relative volume candidate